The global medical isotope production market size is calculated at USD 4.71 billion in 2025 and is forecasted to reach around USD 9.69 billion by 2034, accelerating at a CAGR of 8.34% from 2025 to 2034. The North America market size surpassed USD 2.52 billion in 2024 and is expanding at a CAGR of 8.45% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medical Isotope Production Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medical Isotope Production Market, by Isotope Type
8.1.1. Diagnostic Isotopes
8.1.1.1. Market Revenue and Forecast
8.1.2. Therapeutic Isotopes
8.1.2.1. Market Revenue and Forecast
9.1. Medical Isotope Production Market, by Production Technology
9.1.1. Nuclear Reactor-Based Production
9.1.1.1. Market Revenue and Forecast
9.1.2. Fission-based
9.1.2.1. Market Revenue and Forecast
9.1.3. Neutron activation
9.1.3.1. Market Revenue and Forecast
9.1.4. Cyclotron-Based Production
9.1.4.1. Market Revenue and Forecast
9.1.5. Proton acceleration
9.1.5.1. Market Revenue and Forecast
9.1.6. Deuteron-based reactions
9.1.6.1. Market Revenue and Forecast
10.1. Medical Isotope Production Market, by Application
10.1.1. Diagnostic
10.1.1.1. Market Revenue and Forecast
10.1.2. Therapeutic
10.1.2.1. Market Revenue and Forecast
10.1.3. Research Applications
10.1.3.1. Market Revenue and Forecast
11.1. Medical Isotope Production Market, by End-User
11.1.1. Hospitals & Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Diagnostic Imaging Centers
11.1.2.1. Market Revenue and Forecast
11.1.3. Academic & Research Institutes
11.1.3.1. Market Revenue and Forecast
11.1.4. Pharmaceutical & Biotechnology Companies
11.1.4.1. Market Revenue and Forecast
11.1.5. Contract Research Organizations (CROs)
11.1.5.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Isotope Type
12.1.2. Market Revenue and Forecast, by Production Technology
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Isotope Type
12.1.5.2. Market Revenue and Forecast, by Production Technology
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Isotope Type
12.1.6.2. Market Revenue and Forecast, by Production Technology
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Isotope Type
12.2.2. Market Revenue and Forecast, by Production Technology
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Isotope Type
12.2.5.2. Market Revenue and Forecast, by Production Technology
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Isotope Type
12.2.6.2. Market Revenue and Forecast, by Production Technology
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Isotope Type
12.2.7.2. Market Revenue and Forecast, by Production Technology
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Isotope Type
12.2.8.2. Market Revenue and Forecast, by Production Technology
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Isotope Type
12.3.2. Market Revenue and Forecast, by Production Technology
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Isotope Type
12.3.5.2. Market Revenue and Forecast, by Production Technology
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Isotope Type
12.3.6.2. Market Revenue and Forecast, by Production Technology
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Isotope Type
12.3.7.2. Market Revenue and Forecast, by Production Technology
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Isotope Type
12.3.8.2. Market Revenue and Forecast, by Production Technology
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Isotope Type
12.4.2. Market Revenue and Forecast, by Production Technology
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Isotope Type
12.4.5.2. Market Revenue and Forecast, by Production Technology
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Isotope Type
12.4.6.2. Market Revenue and Forecast, by Production Technology
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Isotope Type
12.4.7.2. Market Revenue and Forecast, by Production Technology
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Isotope Type
12.4.8.2. Market Revenue and Forecast, by Production Technology
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Isotope Type
12.5.2. Market Revenue and Forecast, by Production Technology
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Isotope Type
12.5.5.2. Market Revenue and Forecast, by Production Technology
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Isotope Type
12.5.6.2. Market Revenue and Forecast, by Production Technology
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End-User
13.1. Curium Pharma
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. BWX Technologies, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nordion (Canada) Inc. – a Sotera Health company
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cardinal Health
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. NTP Radioisotopes (South Africa)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. SHINE Technologies
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. NorthStar Medical Radioisotopes, LLC
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Rosatom State Atomic Energy Corporation (Isotope JSC)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Eckert & Ziegler Strahlen- und Medizintechnik AG
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Isotopia Molecular Imaging Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description